336 related articles for article (PubMed ID: 33080353)
1. Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide.
Guillo L; Rabaud C; Choy EH; D'Amico F; Danese S; Ng SC; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):481-490. PubMed ID: 33080353
[TBL] [Abstract][Full Text] [Related]
2. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
Parikh R; Widenmaier R; Lecrenier N
Expert Rev Vaccines; 2021 Sep; 20(9):1065-1075. PubMed ID: 34311643
[TBL] [Abstract][Full Text] [Related]
3. Shingrix for Herpes Zoster: A Review.
Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Safonova E; Yawn BP; Welte T; Wang C
Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298
[TBL] [Abstract][Full Text] [Related]
5. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.
Sly JR; Harris AL
Nurs Womens Health; 2018 Oct; 22(5):417-422. PubMed ID: 30145235
[TBL] [Abstract][Full Text] [Related]
7. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
Litt J; Booy R; Bourke D; Dwyer DE; Leeb A; McCloud P; Stein AN; Woodward M; Cunningham AL
Hum Vaccin Immunother; 2020 Dec; 16(12):3081-3089. PubMed ID: 32420793
[TBL] [Abstract][Full Text] [Related]
8. Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.
McGirr A; Van Oorschot D; Widenmaier R; Stokes M; Ganz ML; Jung H; Varghese L; Curran D
Appl Health Econ Health Policy; 2019 Oct; 17(5):723-732. PubMed ID: 31250218
[TBL] [Abstract][Full Text] [Related]
9. A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.
Bharucha T; Ming D; Breuer J
Hum Vaccin Immunother; 2017 Aug; 13(8):1789-1797. PubMed ID: 28426274
[TBL] [Abstract][Full Text] [Related]
10. Time to talk to adults with rheumatic diseases about herpes zoster vaccination.
Pier M; Wolbink G; Boekel L
Lancet Rheumatol; 2024 Apr; 6(4):e247-e251. PubMed ID: 38373432
[TBL] [Abstract][Full Text] [Related]
11. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
[TBL] [Abstract][Full Text] [Related]
12. Zoster vaccine live for the prevention of shingles in the elderly patient.
Zussman J; Young L
Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747
[TBL] [Abstract][Full Text] [Related]
13. Herpes Virus Infections in Kidney Transplant Patients (HINT) - a prospective observational cohort study.
Hamm SR; Saini SK; Hald A; Vaaben AV; Pedersen NW; Suarez-Zdunek MA; Harboe ZB; Bruunsgaard H; Johansen IS; Larsen CS; Bistrup C; Birn H; Sørensen SS; Hadrup SR; Nielsen SD
BMC Infect Dis; 2023 Oct; 23(1):687. PubMed ID: 37845608
[TBL] [Abstract][Full Text] [Related]
14. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
16. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
James SF; Chahine EB; Sucher AJ; Hanna C
Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489
[TBL] [Abstract][Full Text] [Related]
17. [Herpes Zoster Vaccine].
Watanabe D
Uirusu; 2018; 68(1):21-30. PubMed ID: 31105132
[TBL] [Abstract][Full Text] [Related]
18. The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus.
Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ
Intern Med J; 2017 Nov; 47(11):1263-1269. PubMed ID: 28516725
[TBL] [Abstract][Full Text] [Related]
19. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.
Sanford M; Keating GM
Drugs Aging; 2010 Feb; 27(2):159-76. PubMed ID: 20104941
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
